Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis - GlobeNewswire
Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis GlobeNewswire
Integrated Phase I/lll study for proposed biosimilar denosumab to confirm matching efficacy, safety and immunogenicity with reference medicine[1]; Osteoporosis ...
Comments
Post a Comment